Physician profile
Charles Lambert
NPI 1124336607
$2,860.23
in general payments reported to CMS, 2019-2025
14 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $393 · 2022: $64.06 · 2023: $517 · 2024: $1,569 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475 · Travel and Lodging: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,474.81 |
| Travel and Lodging | $928.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,645.32 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bolton Medical INC | $177.98 | 2025 | Thoraflex Hybrid |
| Solventum Corporation | $139.61 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Tactile Systems Technology INC | $132.85 | 2021 | |
| Intuitive Surgical, INC. | $123.77 | 2023-2024 | Da Vinci Surgical System |
| Lifenet Health | $123.50 | 2023 | |
| Baxter Healthcare | $119.93 | 2021 | |
| Boston Scientific Corporation | $115.98 | 2023 | Eluvia |
| Kci USA, INC. | $81.92 | 2021 | |
| Medtronic, INC. | $64.06 | 2022 | |
| Genentech USA, INC. | $46.33 | 2024 | Xolair |
| Stryker Corporation | $38.40 | 2021 | |
| Smith+Nephew, INC. | $33.51 | 2021-2023 | Collagenase Santyl |
| Alcresta Therapeutics, INC. | $17.07 | 2024 | Relizorb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.